Lähteenvuo notes that while more research is called for, drugs like Ozempic may offer hope to those burdened by addiction, ...

A new study has revealed that GLP-1 drugs, commonly used for diabetes and weight loss, show promise in treating alcohol ...

A study published in JAMA Psychiatry found that glucagon-like peptide 1 drugs such as semaglutide and liraglutide can ...

Plus: How AI can make it easier to find drugs from nature and a study suggests Ozempic could treat alcoholism.

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion sales in 2023, it shows no signs ...

"For healthcare providers, these findings suggest that anti-obesity medications may offer dual benefits," one doctor reports ...

People living with HIV may also have to manage other health conditions like cardiovascular disease, type 2 diabetes, ...

GLP-1 Receptor Agonist medications, such as Ozempic, combined with exercise and nutrition, can help reduce obesity, according ...

A new study has shed light on the health risks faced by people who stop using weight-loss medications Ozempic or Wegovy.

英矽智能发布了ISM001-055药物临床试验结果。该药物由生成式人工智能设计，旨在治疗慢性肺病特发性肺纤维化（IPF）。美国约有10万IPF患者，随着病情发展，患者呼吸会愈发困难。